Cargando…

Autoantibodies against four-and-a-half-LIM domain 1 (FHL1) in inflammatory myopathies: results from an Australian single-centre cohort

OBJECTIVES: To determine the prevalence and associations of autoantibodies targeting a muscle-specific autoantigen, four-and-a-half-LIM-domain 1 (FHL1), in South Australian patients with histologically-confirmed idiopathic inflammatory myopathies (IIM) and in patients with SSc. MATERIAL AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galindo-Feria, Angeles S, Horuluoglu, Begum, Day, Jessica, Fernandes-Cerqueira, Catia, Wigren, Edvard, Gräslund, Susanne, Proudman, Susanna, Lundberg, Ingrid E, Limaye, Vidya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Basic Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536793/ https://www.ncbi.nlm.nih.gov/pubmed/35022656 http://dx.doi.org/10.1093/rheumatology/keac003

Ejemplares similares

Aminoacyl-tRNA Synthetases: On Anti-Synthetase Syndrome and Beyond
por: Galindo-Feria, Angeles S., et al.
Publicado: (2022)

Longitudinal assessment of reactivity and affinity profile of anti-Jo1 autoantibodies to distinct HisRS domains and a splice variant in a cohort of patients with myositis and anti-synthetase syndrome
por: Notarnicola, Antonella, et al.
Publicado: (2022)

Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies
por: Fernandes-Cerqueira, Cátia, et al.
Publicado: (2018)

Four and a Half LIM Domains 2 (FHL2) Contribute to the Epithelial Ovarian Cancer Carcinogenesis
por: Wang, Chen, et al.
Publicado: (2020)

Deficiency in four and one half LIM domain protein 2 (FHL2) aggravates liver fibrosis in mice
por: Huss, Sebastian, et al.
Publicado: (2013)

Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury
por: Sommer, Judith, et al.
Publicado: (2020)

Single‐cell profiling of muscle‐infiltrating T cells in idiopathic inflammatory myopathies
por: Argyriou, Alexandra, et al.
Publicado: (2023)

Exome sequencing identifies variants in two genes encoding the LIM-proteins NRAP and FHL1 in an Italian patient with BAG3 myofibrillar myopathy
por: D’Avila, Francesca, et al.
Publicado: (2016)

Deficiency in the LIM-only protein Fhl2 impairs skin wound healing
por: Wixler, Viktor, et al.
Publicado: (2007)

Aberrant Expression of High Mobility Group Box Protein 1 in the Idiopathic Inflammatory Myopathies
por: Day, Jessica, et al.
Publicado: (2020)

The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription
por: Hua, G, et al.
Publicado: (2016)

Four and a Half LIM Domains 1b (Fhl1b) Is Essential for Regulating the Liver versus Pancreas Fate Decision and for β-Cell Regeneration
por: Xu, Jin, et al.
Publicado: (2016)

The LIM-only protein FHL2 interacts with β-catenin and promotes differentiation of mouse myoblasts
por: Martin, Bernd, et al.
Publicado: (2002)

Deficiency of the LIM-Only Protein FHL2 Reduces Intestinal Tumorigenesis in Apc Mutant Mice
por: Labalette, Charlotte, et al.
Publicado: (2010)

The LIM-Only Protein FHL2 Attenuates Lung Inflammation during Bleomycin-Induced Fibrosis
por: Alnajar, Abdulaleem, et al.
Publicado: (2013)

The LIM-Only Protein FHL2 is involved in Autophagy to Regulate the Development of Skeletal Muscle Cell
por: Liu, Zihao, et al.
Publicado: (2019)

How (Epi)Genetic Regulation of the LIM-Domain Protein FHL2 Impacts Multifactorial Disease
por: Habibe, Jayron J., et al.
Publicado: (2021)

Four and a Half LIM Protein 1C (FHL1C): A Binding Partner for Voltage-Gated Potassium Channel K(v1.5)
por: Poparic, Ivana, et al.
Publicado: (2011)

Four-and-a-Half LIM-Domain Protein 2 (FHL2) Induces Neuropeptide Y (NPY) in Macrophages in Visceral Adipose Tissue and Promotes Diet-Induced Obesity
por: Sommer, Judith, et al.
Publicado: (2023)

Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies
por: Leclair, Valérie, et al.
Publicado: (2023)

The LIM Domain Protein BmFHL2 Inhibits Egg Production in Female Silkworm, Bombyx mori
por: Yuan, Qian, et al.
Publicado: (2023)

LIM-only protein FHL2 attenuates vascular tissue factor activity, inhibits thrombus formation in mice and FHL2 genetic variation associates with human venous thrombosis
por: Kroone, Chantal, et al.
Publicado: (2020)

Physical and functional interaction between the HTLV-1 Tax oncoprotein and the cellular LIM domain protein FHL3
por: McCabe, Áine, et al.
Publicado: (2011)

Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy
por: Cowling, Belinda S., et al.
Publicado: (2008)

Novel FHL1 Mutation Associated With Hypertrophic Cardiomyopathy, Sudden Cardiac Death, and Myopathy
por: Binder, M. Scott, et al.
Publicado: (2020)

The LIM-Only Protein FHL2 Mediates Ras-Induced Transformation through Cyclin D1 and p53 Pathways
por: Labalette, Charlotte, et al.
Publicado: (2008)

The LIM-Only Protein FHL2 Reduces Vascular Lesion Formation Involving Inhibition of Proliferation and Migration of Smooth Muscle Cells
por: Kurakula, Kondababu, et al.
Publicado: (2014)

A comprehensive study of skeletal muscle imaging in FHL1 ‐related reducing body myopathy
por: Mohassel, Payam, et al.
Publicado: (2023)

ELISA, protein immunoprecipitation and line blot assays for anti-TIF1-gamma autoantibody detection in cancer-associated dermatomyositis
por: Selickaja, Sandra, et al.
Publicado: (2022)

Novel FHL1 mutation variant identified in a patient with nonobstructive hypertrophic cardiomyopathy and myopathy – a case report
por: Giucă, Adrian, et al.
Publicado: (2020)

The Roles of FHL3 in Cancer
por: Huang, Zhenjun, et al.
Publicado: (2022)

Disease Specific Autoantibodies in Idiopathic Inflammatory Myopathies
por: Stuhlmüller, Bruno, et al.
Publicado: (2019)

Narrative review of autoantibodies in idiopathic inflammatory myopathies
por: Liu, Yilin, et al.
Publicado: (2021)

Outcome predictors of immune-mediated necrotizing myopathy—a retrospective, multicentre study
por: Wang, Jeremy X, et al.
Publicado: (2022)

Secondary myoadenylate deaminase deficiency is not a common feature of inflammatory myopathies: A descriptive study
por: Wilkinson, Michael, et al.
Publicado: (2022)

FHL1 adds some muscle
por: Short, Ben
Publicado: (2008)

The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies
por: Rider, Lisa G., et al.
Publicado: (2013)

Update on autoantibodies and related biomarkers in autoimmune inflammatory myopathies
por: Choi, May Y., et al.
Publicado: (2023)

An Upstream Hfq Binding Site in the fhlA mRNA Leader Region Facilitates the OxyS-fhlA Interaction
por: Salim, Nilshad N., et al.
Publicado: (2010)

Four-and-a-half LIM domains proteins are novel regulators of the protein kinase D pathway in cardiac myocytes
por: Stathopoulou, Konstantina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5nje4d34m25o5cfghn814sp2s3